Comparative study between silver nanoparticles dressing (SilvrSTAT Gel) and conventional dressing in diabetic foot ulcer healing: a prospective randomized study

Faculty of medicine0 个研究点目标入组 80 人开始时间: 2020年6月30日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Inclusion criteria
•1-Type I or II DM on either oral hypoglycemic or insulin therapy.
•2-Presence of revascularized non-ischemic DFUs after successful bypass surgery or endovascular intervention.
•3- Presence of a foot ulcer for at least 6 weeks duration.
•4-No clinical evidence of infection at the ulcers site.
•5-Wagner type I or II ulcers.

•Exclusion criteria
•1-Wagner type III, IV and V ulcers.
•2-Peripheral artery disease (PAD).
•3-Clinical signs of infection.
•4-Presence of gangrene in the ulcer or any part of foot
•5-Patients with a history of suspected osteomyelitis
•6-Surface area of ulcer Ë‚ 2cm2.
•7-Exposure of bone, tendon, and ligament at ulcer bed.
•8-Patients with a history of radiation or chemotherapy within three months of randomization.
•9-Low serum albumin (Ë‚ 3 g/dl).
•10-History of silver hypersensitivity.
•11-Patients on renal dialysis, immunocompromised, history of liver, hematological, nutritional, collagen, and vascular diseases.
•12-Patients with active cancer.

发起方

Faculty of medicine